Last week, TrueSpace finished their Fall Speaker Series by hosting Heather Callender-Potters, CEO of PharmaJet and an entrepreneurial force in healthcare. Heather offered insight to those aspiring to grow their business, focusing on the importance of patience, perseverance, and perspective.
PharmaJet’s needle-free injection is changing the world standard of vaccine delivery by offering the only commercial needle-free technology with regulatory clearance for all three tissue depths. The pioneering PharmaJet Stratis® Needle-Free Injector has U.S. FDA 510(k) marketing clearance, CE Mark and WHO PQS certification to deliver medications and vaccines intramuscularly or subcutaneously. In August 2014, the PharmaJet Stratis® Needle-Free Injector was approved for delivery of an influenza vaccine to deliver needle-free flu shots.
The audience, including 11 partner members, 3 business members, 1 capital partner member, 6 potential partner members, and 33 non-member attendees, were given live demonstration of the PharmaJet needle-free injectors.